SUITE 720, VANCOUVER, A1
Announces Completion of Arrangement with
Securityholders Approve Acquisition by
Other Events
Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order
Amends Agreement with XenoTherapeutics
To Adjourn Special Meeting to September 29, 2025
Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution
Announces Ex-Dividend Date and Nasdaq Due Bill Trading for Previously Announced Cash Distribution
Q3
Q2
Q1
FY 2024
FY 2023
Notice of Suspension of Duty to File Reports
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
S-3ASR
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notification Filed by a National Security Exchange
Post-Effective Amendment to Registration Statement
S-8 POS